Literature DB >> 22056674

A new isocentric technique for exact geometric matching in the radiotherapy of the breast and ipsilateral supraclavicular fossa using dual asymmetric jaws.

Nando Romeo1.   

Abstract

BACKGROUND: In some clinical situations breast or chest wall radiotherapy for cancer is given in association with supraclavicular fossa irradiation. Often the treatment is delivered by two tangential fields to the breast or chest wall and an anterior field that irradiates the supraclavicular region. The tissue between the breast or chest wall and the supraclavicular region may be under or overdosed, because of the junction between the two tangential fields and the anterior field.
PURPOSE: To present a new isocentric technique for exact geometric matching between the two tangential fields and the anterior field.
METHODS: Patients are positioned with both arms raised. Using three-dimensional trigonometry, two half-fields, with isocenter between the breast and the supraclavicular region, are easily matched. The tangential fields have a collimator rotation to protect the lung without additional shielding. The correct gantry, collimator and couch positions are defined for the anterior field to match the tangential fields.
CONCLUSIONS: A general formula for exact geometric matching in radiotherapy of the breast and supraclavicular fossa is presented. The method does not require additional shielding to eliminate divergence other than the four independent jaws. The result is simple to implement in modern delivery facilities.
Copyright © 2011 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22056674     DOI: 10.1016/j.ejmp.2011.10.003

Source DB:  PubMed          Journal:  Phys Med        ISSN: 1120-1797            Impact factor:   2.685


  1 in total

1.  Comparing the monoisocentric and dual isocentric techniques in chest wall radiotherapy of mastectomy patients.

Authors:  Amin Banaei; Bijan Hashemi; Mohsen Bakhshandeh
Journal:  J Appl Clin Med Phys       Date:  2015-01-08       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.